Indie Asset Partners, LLC Quotient LTD Transaction History

Indie Asset Partners, LLC

$129 Million
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 25, 2022	SELL	$0.16 - $0.31 $2,160 - $4,185	-13,500 Reduced 47.37%	15,000 $2,000
Q2 2022 Aug 12, 2022	BUY	$0.24 - $1.2 $960 - $4,800	4,000 Added 16.33%	28,500 $7,000
Q4 2021 Feb 11, 2022	BUY	$1.89 - $3.12 $1,890 - $3,120	1,000 Added 4.26%	24,500 $63,000
Q3 2021 Nov 09, 2021	SELL	$2.34 - $3.77 $2,340 - $3,770	-1,000 Reduced 4.08%	23,500 $55,000
Q1 2021 May 13, 2021	BUY	$3.57 - $6.2 $7,140 - $12,400	2,000 Added 8.89%	24,500 $90,000
Q1 2020 May 13, 2020	SELL	$2.54 - $9.38 $25,908 - $95,676	-10,200 Reduced 31.19%	22,500 $89,000
Q4 2019 Feb 11, 2020	BUY	$7.07 - $9.51 $231,189 - $310,977	32,700 New	32,700 $311,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.